Try our Advanced Search for more refined results

US Coverage

Law360 Authority | Deep News & Analysis

Global Coverage

Law360 Pulse | The Business of Law

Mealeys

MLex

March 07, 2013

Linda Messick v. Novartis Pharmaceuticals Corp.

Track this case

Case Number:

13-15433

Court:

Appellate - 9th Circuit

Nature of Suit:

3365 Personal Injury-Product Liability

Companies

Sectors & Industries:

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. April 04, 2014

    9th Circ. Allows Expert Testimony In Novartis Jaw Injury Row

    The Ninth Circuit on Friday overturned a lower court's order barring an expert from testifying that Novartis Pharmaceuticals Corp.'s bone drugs Aredia and Zometa caused a user to sustain jaw injuries, ruling that the doctor's testimony was not unreliable or irrelevant. 

1 other articles on this case. View all »

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login